David D. Thompson

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

Masahiko Sato, W A Grasser, Naoto Endo et al. · Journal of Clinical Investigation · 1991 · 1K citations · Full text

Medicine, Endocrinology, Bone Augmentation +14

FDA guidelines and animal models for osteoporosis

David D. Thompson, Hollis A. Simmons, C.M. Pirie et al. · Bone · 1995 · 525 citations

Medicine, Animal Sciences, Endocrinology +14

The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats

J.G. Seedor, H. Quartuccio, David D. Thompson · Journal of Bone and Mineral Research · 1991 · 402 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Lasofoxifene in Postmenopausal Women with Osteoporosis

Steven R. Cummings, Kristine E. Ensrud, Pierre D. Delmas et al. · New England Journal of Medicine · 2010 · 383 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +17

Osteopenia in the immobilized rat hind limb is associated with increased bone resorption and decreased bone formation

Miron Weinreb, Gideon A. Rodan, David D. Thompson · Bone · 1989 · 293 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14